Sarbajit Mukherjee

Sarbajit Mukherjee practices at Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida.

Sarbajit Mukherjee's NPI, 1003164427, was assigned on August 15, 2012. Sarbajit Mukherjee graduated from NRS Medical College Calcutta in 2010. Sarbajit Mukherjee holds New York license 292691.

Sarbajit Mukherjee's primary practice is Baptist Health Baptist Hospital, at 8900 N Kendall Dr, Miami, FL 33176 in Miami-Dade County. The practice phone is (786) 596-1960.

Sarbajit Mukherjee's primary practice is Baptist Health Baptist Hospital in Miami, Florida, part of Baptist Health South Florida. The medical group on file is Baptist Health Medical Group Oncology. Dmand AI also links Sarbajit Mukherjee to 1 more breast imaging center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sarbajit Mukherjee practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Sarbajit Mukherjee's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Sarbajit Mukherjee is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Sarbajit Mukherjee's licenses on file in 4 states: New York, Florida, Oklahoma and Illinois.

Dmand AI lists colorectal cancer and lung cancer among the conditions Sarbajit Mukherjee treats.

CMS data shows 136 Medicare services from Sarbajit Mukherjee across 3 procedure codes in 2024, all of them office visits, for 50 Medicare patients. Medicare paid $13,151 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 50 Medicare patients who saw Sarbajit Mukherjee in 2024. The largest group is 65 to 74, with 22 patients. 70% of them have high blood pressure, and 56% have high cholesterol. Their average risk score is 2.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sarbajit Mukherjee's median patient age at 70, with 40% women.

In 2024, Sarbajit Mukherjee wrote 91 Medicare Part D claims for 46 patients. 86% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $3,659 in total drug cost. In 2019, CMS named 13 claims across 1 drug.

Sarbajit Mukherjee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sarbajit Mukherjee as offering telehealth.

Dmand AI links 62 papers to Sarbajit Mukherjee, published from 2014 to 2025. 2024 was the busiest year, with 9. The most frequent topics are Adenocarcinoma, Esophageal Neoplasms and Stomach Neoplasms. Sarbajit Mukherjee has published most often in Cancers (Basel). Sarbajit Mukherjee's most frequent co-authors are Renuka V. Iyer, MD, Sami Ibrahimi, MD and Moshim Kukar, MD.

Dmand AI links Sarbajit Mukherjee to 6 clinical trials, 5 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Adenocarcinoma Of Esophagus, Anal Canal Carcinoma and Esophageal Squamous Cell Carcinoma. Roswell Park Cancer Institute sponsors the most, 2.

CMS Open Payments shows 54 general payments to Sarbajit Mukherjee from 19 drug and device companies from 2016 to 2025. Education make up the largest share, 86% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $201,116.

Dmand AI lists 7 awards for Sarbajit Mukherjee, most recently Board of Directors in 2018.

Sarbajit Mukherjee graduated from NRS Medical College Calcutta in 2010. Sarbajit Mukherjee is a member of American Association for Cancer Research, American College of Gastroenterology, American Society of Clinical Oncology, ASCO and American Society of Hematology.

Sarbajit Mukherjee is in network with 13 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.